Could chemical enhancement of gold nanoparticle penetration be extrapolated from established approaches for drug permeation?

Skin Pharmacology and Physiology

Volumn 25, Issue 4, 2012, Pages 208-218

  Labouta, H I ^a,b   El Khordagui, L K ^b   Schneider, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Chemical penetration enhancement; Gold nanoparticles; Multiphoton microscopy; Particle penetration

Indexed keywords

COLLOIDAL GOLD; DIMETHYL SULFOXIDE; DODECYL SULFATE SODIUM; GOLD NANOPARTICLE; POLYSORBATE 80; UREA;

ARTICLE; COMPARATIVE STUDY; DRUG PENETRATION; DRUG STABILITY; FEMALE; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; PRIORITY JOURNAL; SKIN PENETRATION;

DIMETHYL SULFOXIDE; EPIDERMIS; FEMALE; GOLD; HUMANS; METAL NANOPARTICLES; PERMEABILITY; POLYSORBATES; SKIN ABSORPTION; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; UREA;

EID: 84861645106     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000338688     Document Type: Article

References (42)

1. Wertz PW: Lipids and barrier function of the skin. Acta Derm Venereol Suppl (Stockh) 2000; 208: 7-11.
2. Thong HY, Zhai H, Maibach HI: Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol 2007; 20: 272-282. (Pubitemid 350014982)
3. Kuo TR, Wu CL, Hsu CT, Lo W, Chiang SJ, Lin SJ, Dong CY, Chen CC: Chemical enhancer induced changes in the mechanisms of transdermal delivery of zinc oxide nanoparticles. Biomaterials 2009; 30: 3002- 3008.
4. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Latendresse JR, Warbitton AR, Yu WW, Colvin VL, Walker NJ, Howard PC: Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. Toxicol Sci 2009; 111: 37-48.
5. Xia XR, Monteiro-Riviere NA, Riviere JE: Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol 2010; 242: 29-37.
6. Schneider M, Stracke F, Hansen S, Schaefer UF: Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 2009; 1: 197-206.
7. Bolzinger MA, Briançon S, Chevalier Y: Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011; 3: 463-478.
8. Labouta HI, Kraus T, El-Khordagui LK, Schneider M: Combined multiphoton imaging- pixel analysis for semiquantitation of skin penetration of gold nanoparticles. Int J Pharm 2011; 413: 279-282.
9. Labouta HI, Hampel M, Thude S, Reutlinger K, Kostka KH, Schneider M: Depth profiling of gold nanoparticles and characterization of point spread functions in reconstructed and human skin using multiphoton microscopy. J Biophotonics 2011; 5: 85-96.
10. Ghosh P, Han G, De M, Kim CK, Rotello VM: Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008; 60: 1307-1315.
11. Pissuwan D, Niidome T, Cortie MB: The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011; 149: 65-71.
12. Labouta HI, Schneider M: Tailor-made biofunctionalized nanoparticles using layer-bylayer technology. Int J Pharm 2010; 395: 236- 242.
13. Brown SD, Nativo P, Smith JA, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ: Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010; 132: 4678-4684.
14. Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, Chou CH, Chen DH, Wang CR, Shiau AL, Wu CL: Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007; 4: 713-722. (Pubitemid 350004271)
15. Reum N, Fink-Straube C, Klein T, Hartmann RW, Lehr CM, Schneider M: Multilayer coating of gold nanoparticles with drug-polymer coadsorbates. Langmuir 2010; 26: 16901-16908.
16. Bhumkar D, Joshi H, Sastry M, Pokharkar V: Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 2007; 24: 1415-1426. (Pubitemid 46988207)
17. Wang H, Huang H, Huang X: Differential effects of abscisic acid and ethylene on the fruit maturation of litchi chinensis Sonn. Plant Growth Regul 2007; 52: 189-198. (Pubitemid 47013561)
18. Thomas M, Klibanov AM: Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2003; 100: 9138-9143. (Pubitemid 37033896)
19. Oishi M, Nakaogami J, Ishii T, Nagasaki Y: Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett 2006; 35: 1046-1047. (Pubitemid 44859908)
20. Huang X, Qian W, El-Sayed IH, El-Sayed MA: The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med 2007; 39: 747-753. (Pubitemid 350086409)
21. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K: In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008; 65: 1-10.
22. Krishnan G, Edwards J, Chen Y, Benson HA: Enhanced skin permeation of naltrexone by pulsed electromagnetic fields in human skin in vitro. J Pharm Sci 2010; 99: 2724-2731.
23. Larese Filon F, Crosera M, Adami G, Bovenzi M, Rossi F, Maina G: Human skin penetration of gold nanoparticles through intact and damaged skin. Nanotoxicology 2011; 5: 493-501.
24. Seto JE, Polat BE, Lopez RFV, Blankschtein D, Langer R: Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: comparative in vitro studies with full-thickness and splitthickness pig and human skin. J Control Release 2010; 145: 26-32.
25. Lademann J, Patzelt A, Richter H, Antoniou C, Sterry W, Knorr F: Determination of the cuticula thickness of human and porcine hairs and their potential influence on the penetration of nanoparticles into the hair follicles. J Biomed Opt 2009; 14: 021014.
26. Patzelt A, Richter H, Knorr F, Schaefer U, Lehr CM, Dahne L, Sterry W, Lademann J: Selective follicular targeting by modification of the particle sizes. J Control Release 2011; 150: 45-48.
27. Turkevich J, Stevenson PC, Hillier J: A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951; 11: 55-57.
28. Labouta HI, Kraus T, El-Khordagui LK, Schneider M: Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale 2011; 3: 4989-4999.
29. Wagner H, Kostka KH, Adelhardt W, Schaefer UF: Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 2004; 58: 121-129. (Pubitemid 38781012)
30. Labouta HI, Liu DC, Lin LL, Butler MK, Jeffrey GE, Raphael A, Kraus T, El-Khordagui LK, Soyer HP, Roberts MS, Schneider M, Prow TW: Gold nanoparticle penetration and reduced metabolism in human skin by toluene. Pharm Res 2011; 28: 2931-2944.
31. Schneider G, Decher G: Functional core/ shell nanoparticles via layer-by-layer assembly. Investigation of the experimental parameters for controlling particle aggregation and for enhancing dispersion stability. Langmuir 2008; 24: 1778-1789. (Pubitemid 351500932)
32. Weisbecker CS, Merritt MV, Whitesides GM: Molecular self-assembly of aliphatic thiols on gold golloids. Langmuir 1996; 12: 3763-3772. (Pubitemid 126531338)
33. Asbill CS, Michniak BB: Percutaneous penetration enhancers: local versus transdermal activity. Pharm Sci Technolo Today 2000; 3: 36-41. (Pubitemid 30066493)
34. Walters KA, Bialik W, Brain KR: The effects of surfactants on penetration across the skin. Int J Cosmet Sci 1993; 15: 260-271.
35. Anigbogu ANC, Williams AC, Barry BW, Edwards HGM: Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 1995; 125: 265-282.
36. Roberts MS, Gierden A, Riviere JE, Monteiro- Riviere NA: Solvent and vehicle effects on the skin; in Roberts MS, Walters KA (eds): Dermal Absorption and Toxicity Assessment. New York, Informa Healthcare USA, Inc., 2008, pp 433-448.
37. Lawrence HJ, Walsh D, Zapotowski KA, Denham A, Goodnight SH, Gandara DR: Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 1989; 23: 316-318.
38. Roth SH, Fuller P: Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. J Pain Res 2011; 4: 159-167.
39. Wong KK, Wang GM, Dreyfuss J, Schreiber EC: Absorption, excretion, and biotransformation of dimethyl sulfoxide in man and miniature pigs after topical application as an 80% gel. J Investig Dermatol 1971; 56: 44-48.
40. Sulzberger MB, Cortese TA, Jr., Fishman L, Wiley HS, Peyakovich PS: Some effects of DMSO on human skin in vivo. Ann N Y Acad Sci 1967; 141: 437-450.
41. John H, Laudahn G: Clinical experiences with the topical application of DMSO in orthopedic diseases: evaluation of 4180 cases. Ann N Y Acad Sci 1967; 141: 506-516.
42. Brechner VL, Cohen DD, Pretsky I: Dermal anesthesia by the topical application of tetracaine base dissolved in dimethyl sulfoxide. Ann N Y Acad Sci 1967; 141: 524-531.